| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 人参皂苷TN2; Gynosaponin TN2 | CFN95331 | 77658-95-8 | C42H72O13 = 785.0 | 5mg | QQ客服：2056216494 |
| 三七皂苷L13; Notoginsenoside L13 | CFN95332 | 2485859-56-9 | C47H78O17 = 915.1 | 5mg | QQ客服：3257982914 |
| 9,11-去氢-beta-乳香酸; 9,11-Dehydro-beta-boswellic acid | CFN95335 | 471-65-8 | C30H46O3 = 454.7 | 5mg | QQ客服：2056216494 |
| 开环土贝母苷甲; Secotubeimoside I | CFN95347 | 106235-32-9 | C60H100O30 = 1337.5 | 10mg | QQ客服：1457312923 |
| 川续断皂苷IX; Dipsacussaponin C | CFN95353 | 152406-43-4 | C64H104O30 = 1353.5 | 5mg | QQ客服：1413575084 |
| 日本续断皂甙E1; Japondipsaponin E1 | CFN95354 | 175586-66-0 | C59H96O26 = 1221.4 | 5mg | QQ客服：2159513211 |
| 常春藤皂甙元-3-O-(2-O-乙酰基-α-L-吡喃阿拉伯糖甙); Hederagenin 3-O-(2-O-acetyl-alpha-L-arabinopyranoside) | CFN95355 | 87562-05-8 | C37H58O9 = 646.9 | 10mg | QQ客服：1457312923 |
| 川续断皂苷X; Dipsacus saponin X | CFN95359 | 146100-01-8 | C76H124O40 = 1677.8 | 20mg | QQ客服：2056216494 |
| 冬青苷XLVIII; Ilexoside XLVIII | CFN91698 | 129095-76-7 | C42H66O15 = 811.0 | 5mg | QQ客服：3257982914 |
| 川牛膝皂苷A; Cyaonoside A | CFN91696 | 110081-91-9 | C54H86O23 = 1103.3 | 10mg | QQ客服：1457312923 |
| 川牛膝皂苷B; Cyaonoside B | CFN91695 | 51161-58-1 | C48H76O18 = 941.1 | 10mg | QQ客服：215959384 |
| 茶皂素E1; Theasaponin E1 | CFN91689 | 220114-28-3 | C59H90O27 = 1231.4 | 5mg | QQ客服：2056216494 |
| 茶皂素E2; Theasaponin E2 | CFN91688 | 220114-30-7 | C59H90O27 = 1231.4 | 5mg | QQ客服：1457312923 |
| 黄芪醇; Astragenol | CFN91686 | 86541-79-9 | C30H50O5 = 490.7 | 20mg | QQ客服：3257982914 |
| 桔梗皂苷J; Platycodin J | CFN95395 | 1325614-80-9 | C57H90O29 = 1239.3 | 5mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)